Story

Nebius to Provide Reflection AI With Over $1 Billion in Computing Power

ENTHMSVIIDZHZH-TWJAKOHI
Jul 14, 20261 min read
Nebius to Provide Reflection AI With Over $1 Billion in Computing Power

Summary

Cloud provider Nebius Group NV has entered a multi-year agreement to sell more than $1 billion in computing capacity to Reflection AI, granting the startup access to coveted Nvidia GB300 chips through 2029.

Text size
Background

Nebius Group NV has agreed to sell more than $1 billion in computing power to the artificial intelligence startup Reflection AI, the companies announced Tuesday. The deal, which runs through 2029, provides Reflection AI with crucial access to high-demand Nvidia Corp. GB300 AI chips.

Securing AI Infrastructure

This agreement marks a significant step for Reflection AI in securing the immense computational resources required to develop and train advanced AI models. The startup, founded by two former researchers from Google's DeepMind, is positioning itself as a major player in the rapidly expanding AI landscape.

The deal with Nebius is the second major computing power agreement for Reflection AI in recent months. In June, the company signed a separate multibillion-dollar deal with SpaceX to access the same Nvidia chip model, signaling an aggressive strategy to lock in infrastructure amid a global shortage.

Sample IUX Markets – In-articleAd

Market Context

Reflection AI, which counts Nvidia among its investors, has attracted significant market attention. According to The Wall Street Journal, the company has recently held discussions to raise $2.5 billion at a potential $25 billion valuation, underscoring strong investor confidence in its growth trajectory.

Nebius, based in Amsterdam, specializes in renting AI computing capacity. The company, which separated from Russian internet provider Yandex in 2024, serves a roster of major technology clients that includes Microsoft Corp. and Meta Platforms Inc. This deal further solidifies its role as a key infrastructure provider in the competitive AI sector.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST